MedPath

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection

Conditions
CDI
Microbiome
Clostridium Difficile Infection
Clostridium Difficile
Interventions
Other: No Intervention
Registration Number
NCT04100603
Lead Sponsor
ProgenaBiome
Brief Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

Detailed Description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to infection with C. diff.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Willingness to sign informed consent
  • Diagnosis of C. difficile infection
  • Age of 18 and older
Exclusion Criteria
  • Refusal by patient to sign informed consent form
  • Treatment with antibiotics 2 weeks prior to screening
  • Treatment with probiotics 6 weeks prior to screening
  • History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
  • Postoperative stoma, ostomy, or ileoanal pouch
  • Participation in any experimental drug protocol within the past 12 weeks
  • Treatment with total parenteral nutrition
  • Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
  • Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with CDINo InterventionPatients who are infected with C. diff
Primary Outcome Measures
NameTimeMethod
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing1 year

Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized with C. diff infection

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ProgenaBiome

🇺🇸

Ventura, California, United States

© Copyright 2025. All Rights Reserved by MedPath